NEXGEL, INC. Increase (Decrease) in Deferred Revenue
NEXGEL, INC. (NXGL) reported Increase (Decrease) in Deferred Revenue of -$2.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-17.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDeferredRevenue · last filed 2026-08-17
- NEXGEL, INC. increase (decrease) in deferred revenue for the quarter ending 2025-12-31 was -$178.00K.
- NEXGEL, INC. increase (decrease) in deferred revenue for the quarter ending 2025-09-30 was $0.00.
- NEXGEL, INC. increase (decrease) in deferred revenue for the quarter ending 2025-06-30 was -$106.00K.
- NEXGEL, INC. increase (decrease) in deferred revenue for the quarter ending 2025-03-31 was $107.00K, a 53.48% decline year-over-year.
- NEXGEL, INC. increase (decrease) in deferred revenue for fiscal 2025 was -$177.00K, a 211.32% decline from fiscal 2024.
- NEXGEL, INC. increase (decrease) in deferred revenue for fiscal 2024 was $159.00K, a 695.00% increase from fiscal 2023.
- NEXGEL, INC. increase (decrease) in deferred revenue for fiscal 2023 was $20.00K.
- NEXGEL, INC. increase (decrease) in deferred revenue for fiscal 2021 was -$38.00K, a 200.00% decline from fiscal 2020.
| Period end | Increase (Decrease) in Deferred Revenue 3 month | Increase (Decrease) in Deferred Revenue 6 month | Increase (Decrease) in Deferred Revenue 9 month | Increase (Decrease) in Deferred Revenue 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$2.00K 10-Q · filed 2026-08-17 | |||
| 2025-12-31 | -$178.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | -$178.00K derived: sum of 2 quarters · filed 2026-03-31 | -$284.00K derived: sum of 3 quarters · filed 2026-08-17 | -$177.00K 10-K · filed 2026-03-31 |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | -$106.00K derived: sum of 2 quarters · filed 2026-08-17 | $1.00K 10-Q · filed 2025-11-12 | $1.00K derived: sum of 4 quarters · filed 2026-08-17 |
| 2025-06-30 | -$106.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-17 | $1.00K 10-Q · filed 2026-08-17 | $1.00K derived: sum of 3 quarters · filed 2026-08-17 | $1.00K derived: sum of 4 quarters · filed 2026-08-17 |
| 2025-03-31 | $107.00K 10-Q · filed 2026-05-14 | $107.00K derived: sum of 2 quarters · filed 2026-05-14 | $107.00K derived: sum of 3 quarters · filed 2026-05-14 | $36.00K derived: sum of 4 quarters · filed 2026-05-14 |
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $0.00 derived: sum of 2 quarters · filed 2026-03-31 | -$71.00K derived: sum of 3 quarters · filed 2026-03-31 | $159.00K 10-K · filed 2026-03-31 |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | -$71.00K derived: sum of 2 quarters · filed 2025-11-12 | $159.00K 10-Q · filed 2025-11-12 | $145.00K derived: sum of 4 quarters · filed 2025-11-12 |
| 2024-06-30 | -$71.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | $159.00K 10-Q · filed 2025-08-12 | $145.00K derived: sum of 3 quarters · filed 2025-08-12 | $107.00K derived: sum of 4 quarters · filed 2025-08-12 |
| 2024-03-31 | $230.00K 10-Q · filed 2025-05-13 | $216.00K derived: sum of 2 quarters · filed 2025-05-13 | $178.00K derived: sum of 3 quarters · filed 2025-05-13 | |
| 2023-12-31 | -$14.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27 | -$52.00K derived: sum of 2 quarters · filed 2025-03-27 | $20.00K 10-K · filed 2025-03-27 | |
| 2023-09-30 | -$38.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13 | $34.00K 10-Q · filed 2024-11-13 | ||
| 2023-06-30 | $72.00K 10-Q · filed 2024-08-19 | |||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-28 | $0.00 derived: sum of 2 quarters · filed 2023-03-28 | -$38.00K 10-K · filed 2023-03-28 | |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | -$38.00K 10-Q · filed 2022-11-08 | ||
| 2021-06-30 | -$38.00K 10-Q · filed 2022-08-10 | |||
| 2020-12-31 | $38.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-21 | $38.00K derived: sum of 2 quarters · filed 2022-03-21 | $38.00K 10-K · filed 2022-03-21 | |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | $0.00 10-Q · filed 2021-11-10 | ||
| 2020-06-30 | $0.00 10-Q · filed 2021-08-16 | |||
| 2019-12-31 | $0.00 10-K · filed 2021-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |
| Catheter Precision, Inc. (VTAK) | United States | $0.002B | -0.23 |
| Tenon Medical, Inc. (TNON) | United States | $0.002B | |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Profusa, Inc. (PFSA) | United States | $0.002B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B |